MYLAN 6869 MYLAN 6869 Pill - blue & gray capsule/oblong, 14mm
Pill with imprint MYLAN 6869 MYLAN 6869 is Blue & Gray, Capsule/Oblong and has been identified as Anagrelide Hydrochloride 1 mg. It is supplied by Mylan Pharmaceuticals Inc.
Anagrelide is used in the treatment of Thrombocythemia and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Anagrelide 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 6869 MYLAN 6869
Anagrelide Hydrochloride
- Imprint
- MYLAN 6869 MYLAN 6869
- Strength
- 1 mg
- Color
- Blue & Gray
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous coagulation modifiers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6869 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
crospovidone,
magnesium stearate,
microcrystalline cellulose,
povidone,
sodium lauryl sulfate,
ferrosoferric oxide,
gelatin,
titanium dioxide,
FD&C Blue No. 1,
D&C Yellow No. 10,
FD&C Blue No. 2,
FD&C Red No. 40,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
See also:
PegIntron
PegIntron is used to treat chronic hepatitis C in adults. Learn about side effects, interactions ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Sylatron
Sylatron (peginterferon alfa-2b) used to prevent malignant melanoma from coming back after it has ...
Peginterferon alfa-2b
Peginterferon alfa-2b is used for chronic myelogenous leukemia, hepatitis b, hepatitis c, melanoma ...
More about anagrelide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.